REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

TFBS Bioscience, Inc. (Taiwan, China)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: TFBS Bioscience, Inc. Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

TFBS Bioscience, Inc.is engaged in the inspection of the safety and effectiveness of biotechnical drugs..The company's main products and services include the viral vector manufacturing for cell and gene therapy products, providing biosafety testing and product release testing for cell and gene therapy products, vaccines and biologic products. The company was established in 2016 and is headquartered in New Taipei City, Taiwan.

Headquarters
3F, No.103, Lane 169, Kang-Ning Street, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the TFBS Bioscience, Inc. report to view the information.

Website: http://www.tfbsbio.com

Basic Information
Total Employees:
Purchase the TFBS Bioscience, Inc. report to view the information.
Outstanding Shares:
Purchase the TFBS Bioscience, Inc. report to view the information.
Financial Auditors:
Purchase the TFBS Bioscience, Inc. report to view the information.
Incorporation Date:
May 10, 2016
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
14.2%
Purchase this report to view the information.
8.04%
Purchase this report to view the information.
7.69%
Purchase this report to view the information.
2.69%
Purchase this report to view the information.
2.04%
Company Performance
Financial values in the chart are available after TFBS Bioscience, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-3.95%▼
Total operating revenue
-3.95%▼
Operating profit (EBIT)
-66.9%▼
EBITDA
6.14%▲
Net Profit (Loss) for the Period
-58.58%▼
Total assets
33.76%▲
Total equity
39.54%▲
Operating Profit Margin (ROS)
-11.88%▼
Net Profit Margin
-9.23%▼
Return on Equity (ROE)
-1.52%▼
Quick Ratio
4.95%▲
Cash Ratio
4.57%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo